ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.405
-0.085 (-5.70%)
Mar 31, 2025, 1:23 PM EDT - Market open
ADC Therapeutics Stock Forecast
ADCT's stock price has decreased by -68.6% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 7.75, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 451.60% from the current stock price of 1.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ADC Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +398.22% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +469.40% | Mar 31, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +469.40% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +469.40% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
79.03M
from 70.84M
Increased by 11.56%
Revenue Next Year
92.49M
from 79.03M
Increased by 17.03%
EPS This Year
-1.53
from -1.62
EPS Next Year
-1.23
from -1.53
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 88.0M | 122.4M | 230.5M | ||
| Avg | 79.0M | 92.5M | 162.1M | ||
| Low | 68.2M | 71.5M | 127.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.2% | 54.9% | 149.2% | ||
| Avg | 11.6% | 17.0% | 75.3% | ||
| Low | -3.7% | -9.5% | 38.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.21 | -0.90 |
| Avg | -1.53 | -1.23 |
| Low | -1.82 | -1.67 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.